Anne M. Houdusse

Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Antimalarial cytoskeletal targeting with broad apicomplexan activity.

Antimalarial cytoskeletal targeting with broad apicomplexan activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 24, 2026

Dynamics of the β-cardiac myosin auto-inhibited state explain cardiomyopathy pathogenesis.

Dynamics of the β-cardiac myosin auto-inhibited state explain cardiomyopathy pathogenesis.

Journal: Nature communications

Published: January 16, 2026

Modulation of Filopodial Myosin Function.

Modulation of Filopodial Myosin Function.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Probing protein-protein interactions with drag flow: a case study of F-actin and tropomyosin.

Probing protein-protein interactions with drag flow: a case study of F-actin and tropomyosin.

Journal: The European physical journal. E, Soft matter

Published: April 28, 2025

Coupling between the lever arm and active site via an N-terminal extension tunes force sensitivity in the myosin-1 family.

Coupling between the lever arm and active site via an N-terminal extension tunes force sensitivity in the myosin-1 family.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 07, 2025

Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically.

Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically.

Journal: Nature communications

Published: February 28, 2025

Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential.

Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential.

Journal: bioRxiv : the preprint server for biology

Published: October 17, 2024

Development of clinically viable non-muscle myosin II small molecule inhibitors.

Development of clinically viable non-muscle myosin II small molecule inhibitors.

Journal: Cell

Published: September 24, 2024

Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

Journal: The EMBO journal

Published: April 23, 2024

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction.

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2023

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction.

Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction.

Journal: Nature communications

Published: October 30, 2023

A weak coupling mechanism for the early steps of the recovery stroke of myosin VI: A free energy simulation and string method analysis.

A weak coupling mechanism for the early steps of the recovery stroke of myosin VI: A free energy simulation and string method analysis.

Journal: PLoS computational biology

Published: October 07, 2023

Showing 1-12 of 71

Last Updated: 09/26/2026